ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1281 • ACR Convergence 2020

    Opioid-Related Encounters as a Predictor of 30-Day Readmissions in Lupus

    Christie Bartels1, Maria Schletzbaum2, Yi Chen3 and Amy Kind4, 1University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI, 2University of Wisconsin-Madison School of Medicine and Public Health, Department of Population Health Sciences, Madison, WI, 3University of Wisconsin School of Medicine and Public Health, Department of Biostatistics and Medical Informatics, Madison, WI, 4University of Wisconsin-Madison School of Medicine and Public Health, Department of Medicine, Health Services and Care Research Program, Geriatrics Division, Madison, WI

    Background/Purpose: One in four Medicare hospitalizations with systemic lupus erythematosus (SLE) results in readmission within 30 days, with “injuries and poisonings” as the second most…
  • Abstract Number: 1287 • ACR Convergence 2020

    Prevalence of Morbidity Prior to Diagnosis of Incident Systemic Lupus Erythematosus in the Danish Population

    Julia Simard1, Mikkel Faurschou2, Soeren Jacobsen2 and Renata Hansen2, 1Stanford Medicine, Stanford, CA, 2Copenhagen Lupus and Vasculitis Clinic, Copenhagen, Denmark

    Background/Purpose: Patients with SLE experience a high burden of various comorbidities at disease onset and during disease progression. Studies of excess morbidity prior to SLE…
  • Abstract Number: 1286 • ACR Convergence 2020

    Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity

    May Choi1, Emma Stevens2, Hongshu Guan2, Daniel Li3, Jack Ellrodt4, Benjamin Kargere4, Tianrun Cai2, Kazuki Yoshida5, Brendan Everett2 and Karen Costenbader6, 1Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Brigham and Women's Hospital, Boston, MA, 3Harvard, Columbus, OH, 4Williams College, Williamstown, 5Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: The risk of cardiovascular disease (CVD), including myocardial infarction and stroke, is higher in SLE than in the general population. The excess risk of…
  • Abstract Number: 1292 • ACR Convergence 2020

    Frequency and Predictors of Influenza Vaccine Hesitancy in Systemic Autoimmune Rheumatic Diseases

    Valeria Valerio1, Mariana Useche1, Mianbo Wang2, Sasha Bernatsky3, Christian Pineau4 and Ines Colmegna1, 1The Research Institute of the McGill University Health Centre, Montreal, Canada, 2Lady Davis institute for Medical Research, Montreal, QC, Canada, 3The Research Institute of the McGill University Health Centre, Montreal, ON, Canada, 4McGill University Health Center, Montreal, QC, Canada

    Background/Purpose: Patients with systemic autoimmune rheumatic diseases (SARDs) benefit from getting annual inactivated influenza vaccine (IIV). However, vaccine uptake among SARDs is suboptimal.  The delay…
  • Abstract Number: 1294 • ACR Convergence 2020

    Prediction of Damage in SLE Using Unbiased Analysis of Large Datasets

    Eric Morand1, Dinith Liyanage2, Rita Hoang2, Vera Golder2, Worawit Louthrenoo3, Shue Fen Luo4, Yeong-Jian Wu5, Sargunan Sockalingam6, Susan Morton7, Sandra Navarra8, Leonid Zamora9, Laniyati Hamijoyo10, Yasuhiro Katsumata11, Masayoshi Harigai12, Madelynn Chan13, Sean O'Neill14, Fiona Goldblatt15, Chak Sing Lau16, Zhanguo Li17, Julie Bonin2, Rachel Koelmeyer2, Mandana Nikpour18, Rangi Kandane-Rathnayake2 and Hieu Nim2, 1Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 2Monash University, Clayton, Victoria, Australia, 3Chiang Mai University Hospital, Muang, Thailand, 4Chang Gung Memorial Hospital-Linkou, Taoyuan, Taipei, Taiwan (Republic of China), 5Chang Gung Memorial Hospital, Guishan, Taiwan (Republic of China), 6University of Malaya, Kuala Lumpur, Malaysia, 7Monash Health, Clayton, Victoria, Australia, 8University of Santo Tomas, Manila, Philippines, 9University of Santo Thomas, Manila, Philippines, 10University of Padjadjaran, Bandung, Indonesia, 11Tokyo Women's Medical University School of Medicine, Tokyo, Japan, 12Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan, 13Tan Tock Seng Hospital, Singapore, Singapore, 14Sydney University, Sydney, Australia, 15Royal Adelaide Hospital, Adelaide, Australia, 16Hong Kong University, Hong Kong, Hong Kong, 17Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China (People's Republic), 18The University of Melbourne at St. Vincent's Hospital, Melbourne, Victoria, Australia

    Background/Purpose: A key goal of treatment of SLE is the prevention of irreversible organ damage. The ability to identify patients at increased risk for damage…
  • Abstract Number: 1289 • ACR Convergence 2020

    Sex Differences in Mental Health and Quality of Life and Their Impact in the Treatment of Patients with Systemic Lupus Erythematosus

    Lilian Cano-Cruz1, Eduardo Aguirre-Aguilar1, Martín Valdez-López2, Ana Barrera-Vargas1, Virginia Pascual Ramos1 and Javier Merayo-Chalico3, 1INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRAN, Mexico City, Distrito Federal, Mexico, 2INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRAN, Mexico City, Mexico, 3INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRAN, Ciudad de Mexico, Distrito Federal, Mexico

    Background/Purpose: Systemic lupus erythematosus (SLE) predominantly affects young women. It is usually more aggressive in men and carries a worse prognosis. Information about gender differences…
  • Abstract Number: 1284 • ACR Convergence 2020

    Application of a Novel Method for Determination of Muscle Mass Relative to Fat Mass in Women with Systemic Lupus Erythematosus and Association with Disability

    Sarah Lieber1, Patricia Katz2, Joshua Baker3, Deanna Jannat-Khah4, Dina Sheira1 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2University of California, San Francisco, Novato, CA, 3University of Pennsylvania, Philadelphia, PA, 4Hospital for Special Surgery, New York City, NY

    Background/Purpose: Patients with SLE are at risk for both skeletal muscle loss and increased adiposity, which may predispose to worse health-related quality of life. Decreased…
  • Abstract Number: 1297 • ACR Convergence 2020

    Lupus Antibodies in Relation to Malignancy

    Sarah Huse1, Jim Oates2, Gary Gilkeson3 and Diane Kamen1, 1Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC, Charleston, SC, 3Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic Lupus Erythematosus (SLE) a chronic inflammatory autoimmune disease that has the potential to affect every organ system. Studies have shown increased risk of…
  • Abstract Number: 1300 • ACR Convergence 2020

    Identifying Cognitive Impairment in Patients with Systemic Lupus Erythematosus Using Hidden Markov Models: A Bayesian Approach

    Juan Pablo Diaz-Martinez1, Kathleen Bingham2, Robin Green3, Dorcas Beaton4, Mahta Kakvan1, Lesley Ruttan3, Carmela Tartaglia5, Marvin Fritzler6, May Choi7, Jiandong Su1, Dennisse Bonilla1, Nicole Anderson1, Joan Wither1, Patricia Katz8 and Zahi Touma9, 1University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 2Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 3Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada, 4Institute for Work & Health, Toronto, Canada, 5University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, 6Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 7Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 8University of California, San Francisco, Novato, CA, 9University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network; Krembil Research Institute, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment (CI) is usually operationalized on the American College of Rheumatology Neuropsychological Battery (ACR-NB) as a z-score of ≤-1.5 on ≥2 domains or…
  • Abstract Number: 1301 • ACR Convergence 2020

    Characterizing How SLE Patients Access Health Information Pre and During COVID-19

    Francesca Cardwell1, Susan Elliott2, May Choi3, Ricky Chin4 and Ann Clarke5, 1University of Waterloo, Burlington, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5University of Calgary, Calgary, Canada

    Background/Purpose: The spread of misinformation related to COVID-19 has been especially acute for SLE patients as unsubstantiated claims regarding the efficacy of antimalarials for COVID-19…
  • Abstract Number: 1296 • ACR Convergence 2020

    Associations of Metabolic Syndrome and Adipokines in SLE

    Diane Apostolopoulos1, Fabien Vincent2, Rachel Koelmeyer2, Alberta Hoi1 and Eric Morand3, 1Monash University, Melbourne, Victoria, Australia, 2Monash University, Clayton, Victoria, Australia, 3Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia

    Background/Purpose: Metabolic syndrome (MetS) is a chronic pro-inflammatory and pro-thrombotic state associated with increased atherosclerosis, cardiovascular events and type 2 diabetes. It is diagnosed in…
  • Abstract Number: 1307 • ACR Convergence 2020

    Detecting Subtle Changes in Fundoscopic Retinal Images in Patients with Axial Spondyloarthritis with Deep Learning

    Yun Ju Huang1, Chang-Fu Kuo2, Yu Huei Huang3, Yih Shiou Hwang4 and Chihung Lin5, 1Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital and Chang Gung University, New Taipei City, Taiwan (Republic of China), 2Chang Gung Memorial Hospital, Taoyuan, Taiwan (Republic of China), 3Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan city, Taiwan (Republic of China), 4Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan city, Taiwan (Republic of China), 5Chang Gung Memorial Hospital, Taoyuan city, Taiwan (Republic of China)

    Background/Purpose: Fundoscopy is essential to identify the retinopathy of patients with autoimmune diseases. However, the classification of different autoimmune diseases is difficult by human eyes…
  • Abstract Number: 1304 • ACR Convergence 2020

    Uveitis Occurrence in Early Inflammatory Back Pain: Five Years Data from a Prospective French Nationwide Cohort

    Daniel Wendling1, Clement Prati2, Thierry Lequerre3, Corinne Miceli-Richard4, Maxime Dougados5, Anna Molto6 and Xavier Guillot7, 1CHU Besançon, department of rheumatology, Besancon, France, 2Rheumatology, University Teaching Hospital, Besançon, France, 3Rheumatology, University Teaching Hospital, Rouen, France, 4Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, 5Department of Rheumatology, Hopital Cochin, Université de Paris, Paris, France, 6Rheumatology Department, Cochin Hospital, APHP, Paris, France, Paris, France, 7CHU Reunion, Saint Denis, Reunion

    Background/Purpose: Uveitis is the most frequent extra rheumatological manifestation in axial Spondyloarthritis (SpA). DESIR is a prospective multicenter cohort of patients with early inflammatory back…
  • Abstract Number: 1299 • ACR Convergence 2020

    Longitudinal Patterns of Anxiety Symptomology Among Patients with Systemic Lupus Erythematosus (SLE) Remain Stable over Time and Do Not Associate with SLE Disease Activity

    Daphne Lew1, Xinliang Huang2, Sara Kellahan2, Hong Xian3, Seth Eisen4 and Alfred Kim5, 1Washington University in St. Louis School of Medicine, Saint Louis, MO, 2Division of Rheumatology, Washington University in St. Louis School of Medicine, St. Louis, 3Department of Epidemiology and Biostatistics, College for Public Health and Social Justice, Saint Louis University, St. Louis, 4Washington University School of Medicine, St Louis, MO, 5Washington University School of Medicine, St. Louis, MO

    Background/Purpose: Almost 40% of patients with SLE have comorbid mental health conditions.1 Though depression is most commonly reported (24% to 30%), many SLE patients also…
  • Abstract Number: 1191 • ACR Convergence 2020

    Specificity for Inflammatory Pathways Associated with Coronary Microvascular Dysfunction in Rheumatoid Arthritis

    Brittany Weber1, Zeling He1, Sicong Huang1, Daniel H. Solomon2, Elena Massarotti1, Charlotte Golnik1, Thany Seyok1, Seth Brownmiller1, Laurel Martell1, Leann Barrett1, Courtney Bibbo1, Marcy Bolster3, Marcelo DiCarli1 and Katherine Liao1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 3Massachusetts General Hospital, Concord, MA

    Background/Purpose: Coronary microvascular disease (CMD) is associated with increased mortality in RA independent of traditional cardiovascular (CV) risk factors. Inflammation likely plays an important role…
  • « Previous Page
  • 1
  • …
  • 711
  • 712
  • 713
  • 714
  • 715
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology